Diagnosis, pathogenesis and treatment of the myeloproliferative disorders essential thrombocythemia, polycythemia vera and essential megakaryocytic granulocytic metaplasia and myelofibrosis

Netherlands Journal of Medicine - Tập 54 - Trang 46-62 - 1999
J.J. Michiels1, J. Kutti1, P. Stark1, M. Bazzan1, L. Gugliotta1, R. Marchioli1, M. Griesshammer1, P.J.J. van Genderen1, J. Brière1, J.J. Kiladjian1, T. Barbui1, G. Finazzi1, N.I. Berlin1, T.C. Pearson1, A.C. Green1, S.M. Fruchtmann1, R.T. Silver1, E. Hansmann1, A. Wehmeier1, E. Lengfelder1
1Department of Clinical Hematology, Academic Medical Center, Amsterdam, The European Working Group on Myeloproliferative Disorders (EWG.MPD), and Goodheart Institute, MPD Center Europe, Erasmus Tower, Veenmos 13 NL-3069 AT Rotterdam, The Netherlands